Jan 30 (Reuters) - BioInvent:
* Q4 ‍NET SALES AMOUNTED TO SEK 14 (31) MILLION​ * Q4 ‍EARNINGS AFTER TAX SEK -33 (-7.3) MILLION * Q4 CASH FLOW FROM OPERATING ACTIVITIES AND INVESTMENT ACTIVITIES SEK -29 (-24) MILLION​ Source text for Eikon: Further company coverage: (Reporting By Stockholm newsroom)
 